Blockchain Registration Transaction Record

Beam Therapeutics to Present Data on BEAM-101 Trial at EHA 2025 Congress

Beam Therapeutics announces presentation of BEAM-101 trial data at EHA 2025 Congress, showcasing potential breakthrough treatment for sickle cell disease.

Beam Therapeutics to Present Data on BEAM-101 Trial at EHA 2025 Congress

This news matters as it showcases Beam Therapeutics' innovative approach to genetic medicines, specifically in treating sickle cell disease. The updated data from the BEACON trial highlights the potential for a breakthrough treatment that could provide long-term relief for patients suffering from SCD.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x63acfe47a76ef640df7d955052095cbfc53a119a25748a34da9c0bd9ab178445
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintrushkwVM-1ba75a2d5e564e7e2231cb99ac4cdd06